From Ft. Detrick to the Gates Foundation to GSK – The Curious History of the Bone-Break Fever Vaccine

Born in a laboratory at Fort Detrick, Maryland, home to the USA’s biological warfare program, the US Army created, Bill Gates Foundation funded and GSK administered Dengue “Bone-Break” Fever vaccine is reported to be in advanced trials in Thailand.
While one may sincerely wish that a dengue fever vaccine that actually works is being developed the track record of the parties involved, be it the Gates Foundation, GSK or the US Army has to leave any informed observer suspicious if not more than a little paranoid.

The Curious History of the Bone-Break Fever Vaccine

GMOs – An Exploding Time Bomb

There can be little doubt that genetically engineered crops are the most dangerous aspect of modern agriculture. Not only are we seeing rapid emergence of super-weeds resistant to glyphosate, courtesy of Roundup Ready crops, we now also have evidence of emerging Bt-resistant insects. Add to that the emergence of a brand new organism capable of producing disease and infertility in both plants and animals, and a wide variety of evidence showing harm to human health, and the only reasonable expectation one can glean is that humanity as a whole is being seriously threatened by this foolhardy technology.
http://articles.mercola.com/sites/articles/archive/2012/05/29/genetically-modified-crops-insects-emerged.aspx

Fight oil with water – Give ClearWater

ClearWater, a community-led project that is providing immediate relief to the people of the Ecuadorean Amazon. The same powerful communities that have been waging a 19-year battle to bring Chevron to justice for its toxic legacy in the Amazon are now building safe drinking water systems for themselves. http://ran.org/tell/clearwater/

Scientist’s Creed

Many people have a vested interest in having you believe things that are not true. Do not accept what is not real to you, no matter from whom it comes.

Learn
The Scientist’s Creed

Ultra-sensitive biosensor could detect diseases in their earliest stages

A new ultra-sensitive test developed by scientists from the Imperial College London and Spain’s University of Vigo has the potential to detect the earliest stages of a disease, thereby giving any treatment the best possible chance of succeeding. The researchers claim their new biosensor test is capable of detecting biomarkers (molecules which indicate the presence of a disease) at concentration levels much lower than is possible with existing biosensors. While the new test has already proven capable of detecting a biomarker associated with prostate cancer, the team says their biosensor could be easily reconfigured to detect biomarkers related to other diseases or viruses. http://www.gizmag.com/ultra-sensitive-biosensor/22703/